Lexitas Pharma Services, a Leading Ophthalmology CRO, Announces the Acquisition of Erie Retina Research, CASExERIE and Element Erie – Business Wire

Lexitas Pharma Services, a Leading Ophthalmology CRO, Announces the buyout of Erie Retina Research, CASExERIE and Element Erie  Business Wire

Source: news.google.com

Leave a Comment

Your email address will not be published. Required fields are marked *